Libra Drugs (India) Pvt Ltd, a active private limited company, was established on 12 August 1992 in Pune, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232PN1992PTC068152. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.02 M.
It upholds a compliant status. Its leadership includes Amar Parge Rajaram (Managing Director), Abhay Rajaram Parge (Whole-Time Director), Umesh Rajaram Parge (Director). Past directors included Kamalini Rajaram Parge, Amar Parge Rajaram, Rajaram Bapusaheb Parge. It holds ₹6.65 M open charges and ₹1.11 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Cts No 145 146 92 B Mangalwarpeth, Pune, Maharashtra, 411011.
U24232PN1992PTC068152
068152
12 August 1992
₹2.50 M
₹2.02 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Libra Drugs (India) Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amar Parge Rajaram | Managing Director | 12 Aug 1992 | Current |
| Abhay Rajaram Parge | Whole-Time Director | 23 Jan 2007 | Current |
| Umesh Rajaram Parge | Director | 27 May 1994 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 25 Jun 2018 | Past |
| Pramod Abcsdd | Whole-Time Director | 14 Mar 2024 | Past |
| Pramod Abcsdd | Managing Director | 12 Sep 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Libra Drugs (India) Pvt Ltd, for the financial year ended 2021, experienced significant reduction in revenue, with a 39.41% decrease. The company also saw a substantial fall in profitability, with a 100.29% decrease in profit. The company's net worth dipped by a decrease of 0.2%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Libra Drugs (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹6,648,000.00
₹1,114,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Mar 2025 | Bank Of India | ₹3.00 M | Open |
| 05 Mar 2025 | Others | ₹3.65 M | Open |
| 26 Mar 2014 | Bank Of India | ₹0.96 M | Satisfied |
| 03 Aug 2001 | Bank Of India | ₹0.15 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Libra Drugs (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Libra Drugs (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Libra Drugs (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Bank Of India amounted to Rs. 3.00 M with Charge ID 101065540 was registered on 07 Mar 2025. was documented.
A charge registered on 26 Mar 2014 via Charge ID 10495035 with Bank Of India was fully satisfied on 06 Mar 2025. was recorded as a recent event.
A charge registered on 03 Aug 2001 via Charge ID 90091629 with Bank Of India was fully satisfied on 06 Mar 2025. was recorded as a recent event.
A charge with Others amounted to Rs. 3.65 M with Charge ID 101058771 was registered on 05 Mar 2025. was recorded as a recent event.
The activity Libra Drugs (India) Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Libra Drugs (India) Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was recorded as a recent event.
The CIN of Libra Drugs (India) Pvt Ltd is U24232PN1992PTC068152.
Libra Drugs (India) Pvt Ltd is headquartered at Cts No 145 146 92 B Mangalwarpeth, Pune, Maharashtra, 411011.
Libra Drugs (India) Pvt Ltd was incorporated on 12 August 1992.
The current directors of Libra Drugs (India) Pvt Ltd are
The primary industry of Libra Drugs (India) Pvt Ltd is Trade.
Libra Drugs (India) Pvt Ltd is unlisted.
The authorized capital of Libra Drugs (India) Pvt Ltd is ₹2.50 M, and the paid-up capital is ₹2.02 M.
The compliance status of Libra Drugs (India) Pvt Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
_PVT_LTD.webp)
Company Details
+91-XXXXXXXXXX